SARA DIACIK: Open Payments
NPI 1770243636 · FLEMINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 12 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $135 |
| Alnylam Pharmaceuticals Inc. | 5 | $93 |
| ABIOMED | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| AtriCure, Inc. | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: LEQVIO, ONPATTRO, KEVEYIS, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, LifeVest.
Industry payments across NJ — which companies pay providers there.
